VIRTUAL CONFERENCE
From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You’ll hear from experts at Deloitte, Ernst & Young, CFGI, life science analysts and your industry counterparts.
LEARNING OBJECTIVES:
- Understand the latest accounting changes in key areas
- Recognize the timelines and key factors affecting the life science industry
- Begin to assess the effects of these standards on your company or clients
REGISTRATION INFORMATION:
Cost: $545
This event will run approximately 8:45-4:40p (Eastern Time) each day.
Register any one of three ways:
1. Register online using a credit card and click the orange button
2. Register by phone at (610) 789-3110
3. Email your contact info to be invoiced to mtarman@acslive.com
| Agenda: DAY 1 | ||
|---|---|---|
| 8:45 | 10:15 | Accounting & Reporting Update: SEC Comment Letter themes MD&A Update Changing regulatory environment Non-GAAP measures ICFR material weaknesses Cybersecurity disclosures |
| 10:15 | 10:30 | Break |
| 10:30 | 11:45 | Revenue Recognition Update Cases and examples Interaction of 808 and 606 Evaluating “active participation” Measure of progress SEC comment letter themes ASC 606 Implementation issues and lessons learned in the life science industry |
| 11:45 | 12:25 | Lunch |
| 12:25 | 1:55 | Valuation Update Fair value accounting Industry standards for valuation models Valuing IPR&D projects Valuation and impairment of intangible assets |
| 1:55 | 2:05 | Break |
| 2:05 | 3:05 | Inventory Accounting Update |
| 3:05 | 3:10 | Break |
| 3:10 | 4:40 | Trends in IPOs and SPAC Transactions Accounting considerations Typical steps IPO Trends Unicorns and timing give IPOs a lift Geopolitical and trade issues Outlook |
| Agenda: DAY 2 | ||
|---|---|---|
| 9:00 | 10:05 | ESG (Environmental, Social and Governance) Update |
| 10:10 | 10:20 | Break |
| 10:20 | 11:40 | Cybersecurity in Life Sciences Recent Trends Cases and Examples New threats from COVID Cybersecurity |
| 11:40 | 11:45 | Break |
| 11:45 | 1:00 | Leadership in the COVID-19 Crisis: Finance and Accounting Implications Trends in disclosure How COVID is impacting controls and compliance Accounting relief |
| 1:00 | 1:30 | Lunch |
| 1:30 | 2:55 | Technology Trends in Life Sciences RPA Data Analytics |
| 2:55 | 3:10 | Break |
| 3:10 | 4:40 | Tax Update R&D Tax Credits Tax Accounting Methods Orphan Drug Credit |
| Conference Series Speakers Include: |
|---|
| Nathan Mitchell Deloitte & Touche, Partner |
| Marcus Lindner Ernst & Young, Senior Manager |
| Kevin Jackson PwC, Director |
| Lindsi Scanlan CFGI, Managing Director |
| Purnima Renjen Deloitte & Touche, IT Director |
| Joseph Segoria Deloitte & Touche, Tax Partner |
| Tom Mantione Ernst & Young, Senior Manager |
| Ryan Dolan CFGI, Partner |
| Melanie Kavanagh CFGI, Managing Director |
| Marcia Deforest Radius
Tax Director |
| Ashley Miranda CFGI
Senior Manager |
| Andrew Trivella Deloitte & Touche, Senior Manager |
| Kelsey Habura Deloitte & Touche, Senior Manager |
| Eliza Biedziak Ernst & Young, Senior Manager |
| Jenny Ciszewski Deloitte & Touche, Partner |
| Serpil Mutlu Tepe Ernst & Young, Manager |
| Alex Althoff Ernst & Young, Senior |
| Whitney Eklund Ernst & Young, Senior Manager |
| Wu Wu Ernst & Young, Senior Manager |
| Mark Marcus Ernst & Young, Senior Manager |
| Kaetlin Liverman Deloitte & Touche, Senior Manager |
| Valerie Vasquez Deloitte & Touche, Partner |